Commentary Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/nephrology.1.003
Usefulness to assess the disease progression and mortality risk profiles, in a population of chronic kidney disease patients followed by general practitioners and nephrologists
Antonio Santoro1,*, Dino Gibertoni2, Marcora Mandreoli3
- 1Specialty School in Nephrology, University of Bologna, Bologna, Italy
- 2Department of Biomedical and Neuromotor Sciences, Unit of Biostatistics, Hygiene and Public Health, University of Bologna, Bologna, Italy
- 3Nephrology and Dialysis Unit, S. Maria della Scaletta Hospital, Imola, Italy
Corresponding Author
Antonio Santoro, antonio.santoro@unibo.it
Received Date: September 04, 2020
Accepted Date: October 06, 2020
Santoro A, Gibertoni D, Mandreoli M. Usefulness to assess the disease progression and mortality risk profiles, in a population of chronic kidney disease patients followed by general practitioners and nephrologists. J Exp Nephrol 2020; 1(1):12-16.
Copyright: © 2020 Santoro A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Commentary on “Discussing diabetes, palliative care and end of life care: choosing the right language”
Our paper entitled “Discussing diabetes, palliative care and end of life care: choosing the right language” reports a core aspect of our research program, which focuses on older people with diabetes, palliative and end of life care for people with diabetes, and the effect of language on clear communication, that commenced in 2009 [1].
Current understanding of gender dimorphism regarding type 2 diabetes
Today, both type 1 and type 2 diabetes mellitus affect 33.3 million people in the United States and nearly 500 million adults worldwide, and there is concern that this number may increase steadily in the future. Previous studies have linked the development of type 2 diabetes to multiple lifestyle factors, including physical activity level and diet, and biological characteristics, such as body composition, age, and race; however, current research suggests that gender may also have an impact on one’s risk of developing type 2 diabetes. Variations in type 2 diabetes diagnosis, prevalence, and progression have been found between males and females.
Potential enhanced association between obstructive lung disease and history of depression in patients with diabetes
Depression is one of the most common comorbidities of chronic diseases including diabetes and obstructive lung diseases (emphysema, chronic bronchitis, and asthma). Obstructive lung diseases and depression have few symptoms in common. However, they are both common in adults and associated with chronic inflammation. It is not clear if their coappearance in diabetic patients is coincidental or associated beyond that expected by chance.
Adiponectin receptor fragmentation in mouse models of type 1 and type 2 diabetes
The protein hormone adiponectin regulates glucose and fatty acid metabolism by binding to two PAQR-family receptors (AdipoR1 and AdipoR2). Both receptors feature a C-terminal segment which is released by proteolysis to form a freely circulating C-terminal fragment (CTF) found in the plasma of normal individuals but not in some undefined diabetes patients.
Systematic evaluation of the effects of exenatide and liraglutide on neurodegenerative diseases induced by type 2 diabetes mellitus
Currently, there are no effective treatment methods for Alzheimer's disease (AD), Parkinson's disease (PD), and olfactory dysfunction (OD). Given common pathophysiological features of neurodegenerative diseases such as AD and type 2 diabetes mellitus (T2DM), antidiabetic drugs such as exenatide and liraglutide, which act as incretin mimetics, are tested as a potential treatment option.